BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36613521)

  • 1. Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling.
    Xu R; He S; Ma D; Liang R; Luo Q; Song G
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plectin Promotes the Migration of Hepatocellular Carcinoma Cells Through Inducing F-actin Polymerization].
    Xu R; Yang L; Song G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):60-66. PubMed ID: 38322534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.
    Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX
    Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Arrestin1 is involved in hepatocellular carcinoma metastasis via extracellular signal-regulated kinase-mediated epithelial-mesenchymal transition.
    Xu X; Lei Y; Zhou H; Guo Y; Liu H; Jiang J; Yang Y; Wu B
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2229-2240. PubMed ID: 32445259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H; Ge C; Sun H; Li H; Li J; Tian H
    Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells.
    Ye T; Xu J; Du L; Mo W; Liang Y; Xia J
    Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
    Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway.
    Chen P; Lei L; Wang J; Zou X; Zhang D; Deng L; Wu D
    Cancer Sci; 2017 Jun; 108(6):1157-1168. PubMed ID: 28375585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AQP5 promotes hepatocellular carcinoma metastasis via NF-κB-regulated epithelial-mesenchymal transition.
    He Z; Dong W; Hu J; Ren X
    Biochem Biophys Res Commun; 2017 Aug; 490(2):343-348. PubMed ID: 28619511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
    Lim WC; Kim H; Ko H
    J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
    Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.